![Peter Dudek](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Dudek
President chez
Merck Research Ventures
Profil
Dr. Peter Dudek is a President at Merck Research Ventures.
He is on the Board of Directors at InduPro, Inc., Caraway Therapeutics, Inc., Tallac Therapeutics, Inc., Mozart Therapeutics, Inc. and Ambagon Therapeutics, Inc.
Dr. Dudek was previously employed as a Principal by Wellington Partners GmbH and an Associate by Entrepreneurs Fund Management LLP.
He also served on the board at Xilio Therapeutics LLC.
He received his undergraduate degree from the University of British Columbia and a doctorate degree from the University of Geneva.
Postes actifs de Peter Dudek
| Sociétés | Poste | Début |
|---|---|---|
Merck Research Ventures
 Merck Research Ventures Investment ManagersFinance Merck Research invests in companies located globally. The firm targets companies operating in the therapeutics sector. It participates in seed and early stage capital requirements with an investment size of up to USD 25 million. The firm acts as a lead and co-lead investor and takes a seat on the board of directors. It also makes follow-on investments and does not invest in medical devices, diagnostic platforms and digital health. | President | 01/03/2021 |
Ambagon Therapeutics, Inc.
 Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Directeur/Membre du Conseil | 01/07/2020 |
Mozart Therapeutics, Inc.
 Mozart Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies to cure autoimmune diseases | Directeur/Membre du Conseil | 01/12/2020 |
InduPro, Inc.
 InduPro, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that specializes in protein therapeutics and cell-surface platform technologies | Directeur/Membre du Conseil | 01/02/2022 |
Caraway Therapeutics, Inc.
 Caraway Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company for the treatment of genetically defined neurodegenerative and rare diseases | Directeur/Membre du Conseil | 01/11/2021 |
Tallac Therapeutics, Inc.
 Tallac Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of immunomodulation polynucleotides | Directeur/Membre du Conseil | 01/11/2021 |
Anciens postes connus de Peter Dudek
| Sociétés | Poste | Fin |
|---|---|---|
Xilio Therapeutics LLC
 Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops cancer biopharmaceuticals | Directeur/Membre du Conseil | 01/02/2021 |
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners invests in companies located in Germany, Europe and beyond. The firm focuses on life sciences companies. It provides financing for early and growth stage capital requirements with an investments size of EUR 2 - 20 million. It also acts as a lead and co-lead investor. | Private Equity Investor | 31/03/2018 |
Entrepreneurs Fund Management LLP
 Entrepreneurs Fund Management LLP Investment ManagersFinance Entrepreneurs Fund invests in companies located primarily in Western Europe. The firm targets companies operating in the fields of life sciences and technology. It provides financing from seed to pre-IPO stages with an investment size of EUR 250k – 10 million. | Analyste en capital-investissement | 01/01/2016 |
Formation de Peter Dudek
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners invests in companies located in Germany, Europe and beyond. The firm focuses on life sciences companies. It provides financing for early and growth stage capital requirements with an investments size of EUR 2 - 20 million. It also acts as a lead and co-lead investor. | Finance |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Geneva
 University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entrepreneurs Fund Management LLP
Entrepreneurs Fund Management LLP Investment ManagersFinance Entrepreneurs Fund invests in companies located primarily in Western Europe. The firm targets companies operating in the fields of life sciences and technology. It provides financing from seed to pre-IPO stages with an investment size of EUR 250k – 10 million. | Finance |
Merck Research Ventures
Merck Research Ventures Investment ManagersFinance Merck Research invests in companies located globally. The firm targets companies operating in the therapeutics sector. It participates in seed and early stage capital requirements with an investment size of up to USD 25 million. The firm acts as a lead and co-lead investor and takes a seat on the board of directors. It also makes follow-on investments and does not invest in medical devices, diagnostic platforms and digital health. | Finance |
Caraway Therapeutics, Inc.
Caraway Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company for the treatment of genetically defined neurodegenerative and rare diseases | Health Technology |
Tallac Therapeutics, Inc.
Tallac Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of immunomodulation polynucleotides | Health Technology |
Ambagon Therapeutics, Inc.
Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Mozart Therapeutics, Inc.
Mozart Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies to cure autoimmune diseases | Health Technology |
Xilio Therapeutics LLC
Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops cancer biopharmaceuticals | Health Technology |
InduPro, Inc.
InduPro, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that specializes in protein therapeutics and cell-surface platform technologies | Commercial Services |
